Atlas Trials

Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT04864522 · WITHDRAWN

Trial details

NCT number
NCT04864522
Sponsor
University of Virginia
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2023-08-01
Primary completion
2023-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.